381 related articles for article (PubMed ID: 26925620)
1. The Brucella melitensis M5-90 phosphoglucomutase (PGM) mutant is attenuated and confers protection against wild-type challenge in BALB/c mice.
Zhang Y; Li T; Zhang J; Li Z; Zhang Y; Wang Z; Feng H; Wang Y; Chen C; Zhang H
World J Microbiol Biotechnol; 2016 Apr; 32(4):58. PubMed ID: 26925620
[TBL] [Abstract][Full Text] [Related]
2. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
Li ZQ; Shi JX; Fu WD; Zhang Y; Zhang J; Wang Z; Li TS; Chen CF; Guo F; Zhang H
Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866
[TBL] [Abstract][Full Text] [Related]
3. The Brucella melitensis M5-90ΔmanB live vaccine candidate is safer than M5-90 and confers protection against wild-type challenge in BALB/c mice.
Zhang J; Yin S; Yi D; Zhang H; Li Z; Guo F; Chen C; Fang W; Wang J
Microb Pathog; 2017 Nov; 112():148-155. PubMed ID: 28916316
[TBL] [Abstract][Full Text] [Related]
4. Development and evaluation of in murine model, of an improved live-vaccine candidate against brucellosis from to Brucella melitensis vjbR deletion mutant.
Li Z; Wang S; Zhang H; Xi L; Zhang J; Zhang X; Zhou Q; Yi J; Li M; Zhang W; Zhang J
Microb Pathog; 2018 Nov; 124():250-257. PubMed ID: 30149131
[TBL] [Abstract][Full Text] [Related]
5. The 16MΔvjbR as an ideal live attenuated vaccine candidate for differentiation between Brucella vaccination and infection.
Wang Y; Bai Y; Qu Q; Xu J; Chen Y; Zhong Z; Qiu Y; Wang T; Du X; Wang Z; Yu S; Fu S; Yuan J; Zhen Q; Yu Y; Chen Z; Huang L
Vet Microbiol; 2011 Aug; 151(3-4):354-62. PubMed ID: 21530111
[TBL] [Abstract][Full Text] [Related]
6. Brucella melitensis 16MΔhfq attenuation confers protection against wild-type challenge in BALB/c mice.
Zhang J; Guo F; Chen C; Li Z; Zhang H; Wang Y; Zhang K; Du G; Li Y; Wang J; Jian T; Wang Z
Microbiol Immunol; 2013 Jul; 57(7):502-10. PubMed ID: 23647412
[TBL] [Abstract][Full Text] [Related]
7. [Effects of Brucella phosphoglucomutase on inducing infection of trophoblastic cells].
Wang Z; Zhang H; Zhang Y; Guo F; Zhang Y; Chen R; Meng R; Li Z; Zhang Q; Chen C
Wei Sheng Wu Xue Bao; 2012 Aug; 52(8):1040-8. PubMed ID: 23173442
[TBL] [Abstract][Full Text] [Related]
8. Brucella melitensis M5-90Δbp26 as a potential live vaccine that allows for the distinction between natural infection and immunization.
Li T; Tong Z; Huang M; Tang L; Zhang H; Chen C
Can J Microbiol; 2017 Aug; 63(8):719-729. PubMed ID: 28482164
[TBL] [Abstract][Full Text] [Related]
9. Brucella abortus 2308ΔNodVΔNodW double-mutant is highly attenuated and confers protection against wild-type challenge in BALB/c mice.
Li Z; Wang S; Zhang J; Yang G; Yuan B; Huang J; Han J; Xi L; Xiao Y; Chen C; Zhang H
Microb Pathog; 2017 May; 106():30-39. PubMed ID: 28131952
[TBL] [Abstract][Full Text] [Related]
10. Rough brucella strain RM57 is attenuated and confers protection against Brucella melitensis.
Feng Y; Peng X; Jiang H; Peng Y; Zhu L; Ding J
Microb Pathog; 2017 Jun; 107():270-275. PubMed ID: 28390976
[TBL] [Abstract][Full Text] [Related]
11. Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats.
Mailybayeva A; Yespembetov B; Ryskeldinova S; Zinina N; Sansyzbay A; Renukaradhya GJ; Petrovsky N; Tabynov K
PLoS One; 2017; 12(10):e0186484. PubMed ID: 29023541
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the immunogenicity and the protective efficacy in mice of a DNA vaccine encoding SP41 from Brucella melitensis.
Al-Mariri A; Abbady AQ
J Infect Dev Ctries; 2013 Apr; 7(4):329-37. PubMed ID: 23592643
[TBL] [Abstract][Full Text] [Related]
13. Protective live oral brucellosis vaccines stimulate Th1 and th17 cell responses.
Clapp B; Skyberg JA; Yang X; Thornburg T; Walters N; Pascual DW
Infect Immun; 2011 Oct; 79(10):4165-74. PubMed ID: 21768283
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a Brucella melitensis mutant deficient in O-polysaccharide export system ATP-binding protein as a rough vaccine candidate.
Wang Z; Niu JR; Wang XL; Wu TL; Cheng J; Lu L; Wu QM
Microbes Infect; 2014 Aug; 16(8):633-9. PubMed ID: 25043564
[TBL] [Abstract][Full Text] [Related]
15. Delta-pgm, a new live-attenuated vaccine against Brucella suis.
Czibener C; Del Giudice MG; Spera JM; Fulgenzi FR; Ugalde JE
Vaccine; 2016 Mar; 34(13):1524-1530. PubMed ID: 26899373
[TBL] [Abstract][Full Text] [Related]
16. The candidate vaccine strain Brucella ovis ∆abcBA is protective against Brucella melitensis infection in mice.
Costa LF; Cabello AL; Batista DFA; Chaki SP; de Figueiredo P; da Paixão TA; Rice-Ficht AC; Ficht TA; Santos RL
Microbiol Immunol; 2020 Nov; 64(11):730-736. PubMed ID: 32965738
[TBL] [Abstract][Full Text] [Related]
17. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
Cloeckaert A; Jacques I; Grilló MJ; Marín CM; Grayon M; Blasco JM; Verger JM
Vaccine; 2004 Jul; 22(21-22):2827-35. PubMed ID: 15246618
[TBL] [Abstract][Full Text] [Related]
18. Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection.
Ghasemi A; Jeddi-Tehrani M; Mautner J; Salari MH; Zarnani AH
Vaccine; 2014 Nov; 32(49):6659-66. PubMed ID: 25240754
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of immune responses in mice and sheep inoculated with a live attenuated Brucella melitensis REV1 vaccine produced in bioreactor.
Curina G; Nardini R; Corneli S; D'Avino N; Tentellini M; Montagnoli C; Severi G; Forti K; Paternesi B; Coletti M; Cagiola M
Vet Immunol Immunopathol; 2018 Apr; 198():44-53. PubMed ID: 29571517
[TBL] [Abstract][Full Text] [Related]
20. Immunization of BALB/c mice with Brucella abortus 2308ΔwbkA confers protection against wild-type infection.
Li ZQ; Gui D; Sun ZH; Zhang JB; Zhang WZ; Zhang H; Guo F; Chen CF
J Vet Sci; 2015; 16(4):467-73. PubMed ID: 26040616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
